Rockefeller Capital Management’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-63
| Closed | -$1K | – | 2917 |
|
|
2022
Q4 | $1K | Hold |
63
| – | – | ﹤0.01% | 3697 |
|
|
2022
Q3 | $1K | Hold |
63
| – | – | ﹤0.01% | 3729 |
|
|
2022
Q2 | $1K | Hold |
63
| – | – | ﹤0.01% | 3962 |
|
|
2022
Q1 | $2K | Sell |
63
-25
| -28% | -$794 | ﹤0.01% | 3612 |
|
|
2021
Q4 | $5K | Sell |
88
-312
| -78% | -$17.7K | ﹤0.01% | 3272 |
|
|
2021
Q3 | $34K | Hold |
400
| – | – | ﹤0.01% | 2326 |
|
|
2021
Q2 | $44K | Sell |
400
-7
| -2% | -$770 | ﹤0.01% | 2139 |
|
|
2021
Q1 | $45K | Sell |
407
-31
| -7% | -$3.43K | ﹤0.01% | 1930 |
|
|
2020
Q4 | $46K | Buy |
438
+167
| +62% | +$17.5K | ﹤0.01% | 1709 |
|
|
2020
Q3 | $37K | Sell |
271
-312
| -54% | -$42.6K | ﹤0.01% | 1596 |
|
|
2020
Q2 | $189K | Buy |
583
+366
| +169% | +$119K | ﹤0.01% | 968 |
|
|
2020
Q1 | $19K | Buy |
+217
| New | +$19K | ﹤0.01% | 1531 |
|